Article May 1, 2018
PTAB's Skyrocketing Petition Rate Starts To Stabilize
- Person title
Principal Tim Riffe was quoted in the Law360 article “PTAB’s Skyrocketing Petition Rate Starts to Stablize” to discuss how patent litigation targets continued to flock to the PTAB in 2015, but the growth of petitions filed has slowed.
“Even if the growth of AIA petitions is flattening out, the PTAB will continue to play a role in patent litigation, particularly since petitioners are relatively likely to obtain a stay in patent litigation after challenging a patent-in-suit at the board, among many other significant benefits for petitioners.”
Read the full article, here.
The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.
Article April 7, 2017
Law360: Celgard Can't Salvage Battery Patent Claims At Fed. Circ.
Article July 17, 2014
9 Common Pitfalls With Post-Grant Proceedings
Article February 3, 2023
Fish & Richardson Attorneys Author IAM Article "Neglect Begets Opportunity in Femtech IP"
Article December 6, 2022
Start of Unified Patent Court Sunrise Period Postponed to 1 March 2023
Article November 18, 2022
Principal Michael Shepherd Authors Law360 Expert Analysis, "Why PTAB 'Step 2B' Reversal Rates Are Falling"
Article October 20, 2022
Life Sciences Entrepreneur Sourcebook | Intellectual Property: What It Is and Why You Should Care
Article October 12, 2022
Principals Matt Colvin and Betsy Flanagan Author IAM Article "Five Tips to Create a Battle-Ready Portfolio From the Get-Go"
Article September 29, 2022
Associate Casey Kraning Authors Article for The National Law Journal "Congress and the America Invents Act — An Update on Recent Developments in the...
Article September 20, 2022
Fish Attorneys Nicholas Stephens and Casey Kraning Author Article in Westlaw Journal IP, "2022 Ushers in New Developments in the Patent Review Process"
Blog September 15, 2022
What to Know About the USPTO's Duty of Candor Guidance Regarding FDA Submissions
Article July 14, 2022
Fish Attorneys John Pegram and Jan Zecher Author Managing IP Article "Will a UPC Opt-out Survive the Transitional Period?"
Article June 14, 2022